Chris Bosh Says He Almost Died in January from Pulmonary Embolism, 'I'm Not Joking'

Former professional basketball player Chris Bosh has revealed that he experienced a life-threatening health crisis in January. According to reporting from Bleacher Report and HoopsHype, Bosh suffered from a pulmonary embolism, stating that he almost dropped dead and essentially came back to life. Bosh emphasized the severity of the situation, explicitly noting that he was not joking about the proximity to death he faced during this medical event. This disclosure highlights the sudden and dangerous nature of the condition he encountered earlier this year. Major sports media outlets including ESPN, Yahoo Sports, and Hoops Rumors are focusing on the cautionary nature of Bosh's experience. The coverage emphasizes a specific message directed toward Victor Wembanyama regarding the management of blood clots.

Bosh is urging Wembanyama to adhere strictly to medical protocols, specifically advising the player to take his medicine. This direct appeal is presented as a critical measure to avoid the type of health scare that Bosh himself endured, turning a personal medical crisis into a public health warning for active athletes. Contextually, this development is significant because it links the health risks of blood clots to high-profile athletes. The coverage provided by ESPN and Yahoo Sports frames this not just as a personal story of survival, but as a directive on medical compliance. By targeting his advice toward Victor Wembanyama, Bosh underscores the vulnerability of professional basketball players to these conditions. The details provided in the HoopsHype Q&A session suggest that the physical toll of such an event is extreme, describing the experience as nearly fatal before a recovery occurred.

Moving forward, the focus remains on the medical advice Bosh has offered and the potential response from Victor Wembanyama. Based on the reporting from Bleacher Report and Hoops Rumors, the primary point of interest is the adherence to medication to prevent further pulmonary embolisms. While coverage does not specify a wider medical campaign, the insistence from Bosh on the necessity of medication serves as the central theme. Observers will likely monitor if this public warning leads to broader discussions regarding blood clot prevention and health monitoring within the professional sports community.